CIC
KZR

Cornercap Investment Counsel’s Kezar Life Sciences KZR Stock Holding History

Cornercap Investment Counsel’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,358
Closed -$87.6K – 621
2023
Q3 		$87.6K Sell
7,358
-99
-1% -$1.75K 0.02% 540
2023
Q2 		$183K Buy
+7,457
New +$194K 0.03% 524

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's KZR Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 7,358 shares — an estimated $87.6K sold.

Cornercap Investment Counsel first reported a position in KZR in Q2 2023 and held it in 2 quarters. The position peaked at $183K in Q2 2023. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 7,358 Kezar Life Sciences shares in Q4 2023, an estimated $87.6K.
  • Cornercap Investment Counsel first reported a position in Kezar Life Sciences in Q2 2023 and held it in 2 quarters.
  • Cornercap Investment Counsel's Kezar Life Sciences position peaked at $183K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.